Recent reports of pathophysiological similarities and cross-neutralization between cholera enterotoxin and thermolabile Escherichia coli strain LT delayed-onset enterotoxin suggest that the two toxins may be identical, or at least very similar, and may share antigenic determinants (2, (6) (7) (8) . We therefore tested paired sera from volunteers immunized with cholera toxoid to determine if toxoid immunization caused an increase in serum antitoxic activity against the Escherichia coli LT delayed-onset enterotoxin. This enterotoxin is designated delayed onset because, as in the case of cholera toxin, there is a delay of several hours between exposure of intestinal mucosa to the toxin and the onset of toxin-induced intestinal fluid accumulation (6, 7 Concentrates (50-fold) of Escherichia coli culture filtrates were prepared by the Evans method (3) using the enterotoxin-producing strain CRL 10400, isolated from a patient with profuse watery diarrhea from whom no other pathogen could be isolated. The toxic filtrate was tested in dog jejunal loops and caused fluid accumulation as previously described (6) .
Assay. A slight modification of the Evans (1) method for rabbitskin toxin assay was made, in that concentrated filtrates were initially diluted 1:25 with borate-gelatin buffer (pH 7.5) and then mixed with equal volumes of the same buffer. A 0.1-ml volume of the resulting mixture was used as the intradermal toxin dose. In our rabbits this amount gave the clearest and most reproducible positive results, and induced an arbitrarily defined positive bluing response with a mean of at least 7 mm of induration, with at least 5 mm of bluing. This response was used as the standard dose of E. coli LT enterotoxin (delayed onset) in the assay. When the standard dose was used as positive controls in duplicate with each set of sera tested, the mean diameter of bluing obtained was 5.9 + 1.5, standard deviation (SD). (Table 1 ). There was no significant rise in vibriocidal titers in the paired sera. This result confirmed the relative freedom of the toxoid vaccine from somatic antigens.
DISCUSSION
Our results, which are consistent with the data derived from recent studies in animals (6) (7) (8) , indicated that in vitro human cholera antitoxin cross-neutralized E. coli strain LT delayed-onset enterotoxin. In the present study the striking parallelism of cholera and E. coli antitoxin titers suggested that both titrations were measuring a single cross-neutralizing antibody which could provide a possible basis for cross-immunity.
Both cholera and diarrhea associated with enterotoxigenic E. coli are endemic in the study population, and repeated infection, often a Antitoxin levels in pre-and postimmunization sera expressed as hemagglutination units (cholera) or neutralizing dilution of serum (E. coli). Dilutions over 1:1,024 were not tested. Zero = no neutralization even with undiluted serum. Group A, Nonresponders; group B, responders.
